Lacarnit 330Mg Tablet

Primarily Lacarnit 330Mg Tablet is used to treat primary systemic carnitine deficiency; acute and chronic treatment of patients with an inborn error of metabolism which results in secondary carnitine deficiency.

Lacarnit 330Mg Tablet essentially controls the levels of levocarnitine, in patients who suffer from problems with metabolism. The drug may also be prescribed in the treatment of other health issues as per the doctor’s decision.

Known to be an amino acid derivative, Lacarnit 330Mg Tablet adds to the levels of levocarnitine in the body, when it is unable to produce sufficient quantities.

I.V. Acute and chronic treatment of patients with an inborn error of metabolism which results in secondary carnitine deficiency is also treated with Lacarnit 330Mg Tablet. This medicine is also used for the prevention and treatment of carnitine deficiency in patients with end-stage renal disease who are undergoing hemodialysis.

The patient’s medical history should be taken before the drug is prescribed. In this case, inform your doctor is you have any kidney or liver issues, or are allergic to any component present in Lacarnit 330Mg Tablet. Inform him if you are on any prescribed or over the counter medicines or taking herbal and dietary supplements.

Pregnant women, those trying to have a baby and breast feeding mothers should consult their doctor before they start Lacarnit 330Mg Tablet.

The drug can be taken either before a meal or even after. Each dosage should be evenly spaced out and taken on time. Avoid missing a dose as much as possible. In case you do miss one dose, taken it immediately when you remember.

All drug cause some minor as well as major side effects and Lacarnit 330Mg Tablet is no exception. Some minor side effects that you may experience because of Lacarnit 330Mg Tablet are cramp in the stomach and abdomen, nausea, headache and diarrhea. Major side effects that may occur are development of hypertension, fever, seizures and irregular heartbeat.

Plasma concentrations should be obtained prior to beginning parenteral therapy, and should be monitored weekly to monthly. In metabolic disorders: monitor blood chemistry, vital signs, and plasma carnitine levels (maintain between 35-60 mmol/L).

In ESRD patients on dialysis: Plasma levels below the normal range should prompt initiation of therapy. Monitor predialysis (trough) plasma carnitine levels.

The oral solution should be consumed slowly and spaced evenly throughout the day to improve tolerance. Although supplemental carnitine has been shown to increase carnitine concentrations, effects on the signs and symptoms of carnitine deficiency have not been determined.

The most common use of this medication is:

• Nutritional Deficiencies

Below are some of the common side effects of this medicine:

• Hypertension

• Peripheral Edema

• Hypercalcemia

• Diarrhoea

• Abdominal Pain

• Vomiting

• Nausea

• Weakness

• Allergic Reaction

• Is It safe with alcohol?

  Complete td tablet may cause excessive drowsiness and calmness with alcohol.

• Are there any pregnancy warnings?

  Complete td tablet may be unsafe to use during pregnancy.
  Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.

• Are there any breast-feeding warnings?

  Complete td tablet is probably unsafe to use during breastfeeding. Please consult your doctor.

• Is it safe to drive while on this medicine?

  There is no data available. Please consult doctor before consuming the drug.

• Does this affect kidney function?

  Hyperkalemia may occur in patients with hepatic or renal impairment

• Does this affect liver function?

  There is no data available. Please consult doctor before consuming the drug.

• How long is the duration of effect?

  This medicine will remain active for about 17.4 hours.

• What is the onset of action?

  The effect of this medicine is initiated within 1 - 3 hours after its intake.

Below is the list of medicines, which have the same composition, strength and form as Lacarnit 330Mg Tablet , and hence can be used as its substitute.

• Nucarnit 330Mg Tablet

  Emcure Pharmaceuticals Ltd

• Are there any overdose instructions?

  Seek emergency medical treatment or contact the doctor in case of an overdose. Usually, no reports of overdose and it is easily removed by dialysis.

• Are there any missed dose instructions?

  If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.

Lacarnit 330Mg Tablet is basically a supplement used for treating low level of carnitine in the blood. Carnitine is required by the body for energy and keeping the body in good health. People with kidney dialysis may have inadequate carnitine in the blood which might result liver, heart and muscle problems.

Whenever you take more than one medicine, or mix it with certain foods or beverages, you"re at risk of a drug interaction.

• Interaction with Medicine

  Concomitant use of Lacarnit 330Mg Tablet along with Valproic acid, sodium benzoate must be avoided.

• Interaction with Disease

  Caution in patients with seizure disorders or in those at risk of seizures (CNS mass or medications which may lower seizure threshold). Both new-onset seizure activity as well as an increased frequency of seizures has been observed.